Oragenics Inc. Stock
Your prediction
Pros and Cons of Oragenics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Oragenics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Oragenics Inc. | - | - | - | - | - | - | - |
| Solasia Pharma KK | 1.560% | -2.290% | 16.364% | -45.763% | -3.759% | -51.880% | -87.327% |
| Larimar Therapeutics Inc. | -1.210% | -5.714% | 18.705% | 11.486% | -0.602% | -13.613% | -61.850% |
| Northwest Biotherapeutics Inc. | 0.000% | -13.548% | -8.844% | -31.633% | -34.951% | -70.485% | -87.358% |
Comments
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat